CVE-2022-0015

Cortex XDR Agent: An Uncontrolled Search Path Element Leads to Local Privilege Escalation (PE) Vulnerability

Description

A local privilege escalation (PE) vulnerability exists in the Palo Alto Networks Cortex XDR agent that enables an authenticated local user to execute programs with elevated privileges. This issue impacts: Cortex XDR agent 5.0 versions earlier than Cortex XDR agent 5.0.12; Cortex XDR agent 6.1 versions earlier than Cortex XDR agent 6.1.9.

Remediation

Solution:

  • This issue is fixed in Cortex XDR agent 5.0.12, Cortex XDR agent 6.1.9, and all later Cortex XDR agent versions.

Workaround:

  • There are no known workarounds for this issue.

Category

7.8
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.17%
Vendor Advisory paloaltonetworks.com
Affected: Palo Alto Networks Cortex XDR Agent
Published at:
Updated at:

References

Link Tags
https://security.paloaltonetworks.com/CVE-2022-0015 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2022-0015?
CVE-2022-0015 has been scored as a high severity vulnerability.
How to fix CVE-2022-0015?
To fix CVE-2022-0015: This issue is fixed in Cortex XDR agent 5.0.12, Cortex XDR agent 6.1.9, and all later Cortex XDR agent versions.
Is CVE-2022-0015 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-0015 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-0015?
CVE-2022-0015 affects Palo Alto Networks Cortex XDR Agent.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.